Table 1.
Traits | Prenatal Testosterone | Prenatal DHT | Interventions—Pathology Manifestations | |||
---|---|---|---|---|---|---|
Prenatal Testosterone + Prenatal Androgen Antagonist | Prenatal Testosterone + Prenatal Insulin Sensitizer | Prenatal Testosterone + Postnatal Androgen Antagonist | Prenatal Testosterone + Postnatal Insulin Sensitizer | |||
Reproductive Traits | ||||||
Advanced puberty | Yes [57] | Yes Ψ [58] | No [57] | No [57] | No [57] | No [57] |
Functional Hyperandrogenism | Yes [23] | Yes [23] | Not tested | Not tested | Not tested | Not tested |
PCO morphology | Yes [31] | No [31] | Not tested | Not tested | Not tested | Not tested |
Disrupted preovulatory LH surge | Yes [57] | No [59] | Partially [57] | Yes [57] | Yes [57] | Yes [57] |
Disrupted estradiol positive feedback | Yes [60] | No [58,59] | Yes [60] | Yes [60] | Partially [60] | Partially [60] |
Disrupted estradiol negative feedback | Yes [26] | Yes [59] | No Σ [61] | Not tested | Not tested | Not tested |
GnRH-stimulated LH hypersecretion | Yes [30] | Yes [30] | Yes [30] | Partially [30] | Yes [30] | No [30] |
Increased follicular recruitment | Yes [33] | Yes [33] | Not tested | Not tested | Not tested | Not tested |
Follicular persistence | Yes [35] | No [36] | Not tested | Not tested | Not tested | Not tested |
Metabolic Traits | ||||||
Insulin resistance | Yes [38,41] | Yes [41] | Yes [41] | No [41] | Yes # | No # |
Altered visceral adiposity | Yes [38] | Not tested | Not tested | Not tested | Not tested | Not tested |
Altered adipocyte size | Yes [38,41] | Not tested | Partially [41] | Partially [41] | Not tested | Not tested |
Adipocyte differentiation | Reduced [39] | Not tested | Partially [39] | Partially [39] | Not tested | Not tested |
Hypertension | Yes [40] | Not tested | Not tested | Not tested | Not tested | Not tested |
Ψ Neuroendocrine puberty; # Unpublished observations: Σ Based on escape from estradiol negative feedback. PCO: polycystic ovary; LH: luteinizing hormone; GnRH: gonadotropin-releasing hormone.